Table 1.
Biomarkers of exposure measured in cord blood: descriptive statistics.
| Biomarker of exposure (unit) | n | Mean ± SD | Median | IQR | Min, Max |
|---|---|---|---|---|---|
| Acrylamide–Hb adducts (pmol/g Hb) | 1,151 | 19.7 ± 16.5 | 14.4 | 10.8, 21.6 | 4.4, 124.8 |
| Glycidamide–Hb adducts (pmol/g Hb) | 1,150 | 13.7 ± 10.4 | 10.8 | 7.9, 15.7 | 2.0, 103.2 |
| Ethylene oxide–Hb adducts (pmol/g Hb) | 1,123 | 13.3 ± 13.8 | 9.4 | 6.6, 14.5 | 0.5, 174.2 |
| M1dG (per 108 nucleotides) | 892 | 53.1 ± 52.5 | 34.2 | 12.2, 82.7 | 0.5, 324.7 |
| PAH–DNA adducts (per 108 nucleotides) | 797 | 1.89 ± 2.09 | 1.39 | 0.58, 2.55 | 0.2, 28.3 |
| Bulky DNA adducts (per 108 nucleotides) | 635 | 11.8 ± 11.2 | 8.4 | 4.8, 15.3 | 0.6, 116.6 |
| O6-MedG (per 108 nucleotides) | 865 | 0.470 ± 0.501 | 0.287 | 0.075, 0.665 | 0.015, 3.033 |
| AR CALUX® (ng DHT AEQ/mL plasma) | 765 | 0.108 ± 0.098 | 0.099 | 0.059, 0.140 | 0.015, 2.142 |
| ERα CALUX® (ng 17-β-estradiol EEQ/mL plasma) | 765 | 22.1 ± 19.4 | 18.2 | 9.5, 28.5 | 0.01, 182.7 |
| DR CALUX® (pg TEQ/mL plasma) | 725 | 0.165 ± 0.137 | 0.130 | 0.055, 0.230 | 0.055, 1.043 |
| Abbreviations: IQR, interquartile range; Max, maximum; Min, minimum. | |||||